154.79
price down icon0.20%   -0.31
after-market Handel nachbörslich: 154.54 -0.25 -0.16%
loading

Finanzdaten der Zoetis Inc-Aktie (ZTS)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
10.81%
2,460.00
2,220.00 2,317.00 2,388.00 2,361.00
Cost Of Revenue
4.34%
649.00
622.00 707.00 701.00 668.00
Gross Profit
13.33%
1,811.00
1,598.00 1,610.00 1,687.00 1,693.00
Operating Expenses
15.36%
909.00
788.00 878.00 813.00 913.00
Interest Income/Expense
1.85%
53.00
54.00 51.00 57.00 59.00
Benefits Costs and Expenses
10.50%
1,558.00
1,410.00 1,585.00 1,514.00 1,581.00
Costs And Expenses
10.50%
1,558.00
1,410.00 1,585.00 1,514.00 1,581.00
Operating Income/Loss
11.36%
902.00
810.00 732.00 874.00 780.00
Nonoperating Income/Loss
122.22%
-4.00
18.00 20.00 16.00 -25.00
Income/Loss From Continuing Operations Before Tax
11.36%
902.00
810.00 732.00 874.00 780.00
Income Tax Expense/Benefit, Deferred
136.84%
-7.00
19.00 -152.00 -42.00 -101.00
Income Tax Expense/Benefit
2.79%
184.00
179.00 151.00 182.00 156.00
Income/Loss From Continuing Operations After Tax
13.79%
718.00
631.00 581.00 692.00 624.00
Net Income/Loss
13.79%
718.00
631.00 581.00 692.00 624.00
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - 10.00 -
Basic Average Shares
0.56%
445.10
447.60 -1.20 452.90 455.50
Diluted Average Shares
0.56%
445.50
448.00 -1.252 453.50 456.00
Basic Earnings Per Share
14.18%
1.61
1.41 1.29 1.51 1.37
Diluted Earnings Per Share
14.18%
1.61
1.41 1.29 1.50 1.37
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
drug_manufacturers_specialty_generic TAK
$14.88
price down icon 1.29%
drug_manufacturers_specialty_generic HLN
$9.63
price down icon 0.47%
$18.15
price up icon 0.17%
$309.22
price up icon 1.26%
$136.84
price up icon 2.13%
Kapitalisierung:     |  Volumen (24h):